Psychedelic Therapy

Research into psychedelics, shut down for decades, is now yielding exciting results - Michael Pollan

Psychedelic Therapy
Psychedelic Therapy

image by: aptmetaphor

HWN Recommends

Can Psychedelics Be Therapy? Allow Research to Find Out

In the last few years, calls for marijuana to be researched as a medical therapy have increased. It may be time for us to consider the same for psychedelic drugs.t

Two general classes of such drugs exist, and they include LSD, psilocybin, mescaline and ecstasy (MDMA).

All are illegal in the United States because they carry a high risk of abuse. They can also cause harm. The best-known adverse event is persistent flashbacks, though these are believed to be rare. More common are symptoms like increased heart rate and blood pressure, anxiety and panic.

Some people have pointed to anecdotal evidence of positive effects. Ayelet Waldman, a novelist and former federal…

read full article

Resources

 Can Psychedelics Be Therapy? Allow Research to Find Out

In the last few years, calls for marijuana to be researched as a medical therapy have increased. It may be time for us to consider the same for psychedelic drugs. Two general classes of such drugs exist, and they include LSD, psilocybin, mescaline and ecstasy (MDMA). All are illegal in the United States because they carry a high risk of abuse. They can also cause harm.

Compass

Founded in 2016, our first major initiative is developing psilocybin therapy through late-stage clinical trials in Europe and North America for patients with treatment-resistant depression. We are taking a new approach to mental health and are committed to developing care pathways and therapies that will help patients and their families, and ease the burden on healthcare systems. Backed by a team of leading experts in medicine, mental health, business, and academia, we put the patient at the centre of everything we do.

Beckley Foundation

Since its creation by Amanda Feilding in 1998, the Beckley Foundation has been at the forefront of global drug policy reform and scientific research into psychoactive substances. We collaborate with leading scientific and political institutions worldwide to design and develop ground-breaking research and global policy initiatives.

Multidisciplinary Association for Psychedelic Studies

Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

The Psychedelic Society

The Psychedelic Society advocates the careful use of psychedelics as a tool for awakening to the unity and interconnectedness of all things. You could say we advocate the use of psychedelics as endosyndelics (from the Greek endosyndesi: interconnection, delos: make visible, reveal). The profound experiences of unity and interconnectedness reliably brought about by strong psychedelic trips can help people to live lives of greater love, compassion and joy

Psychedelic Times

Our mission at Psychedelic Times is to share the latest news, research, and happenings around the study of psychedelics as tools of healing, recovery, and therapy. We are passionate about the incredible potential that psychoactive substances such as marijuana, ayahuasca, MDMA, LSD, iboga, psilocybin, and DMT present to humanity, and are excited to share that passion with you.

Introducing Stitches!

Your Path to Meaningful Connections in the World of Health and Medicine
Connect, Collaborate, and Engage!

Coming Soon - Stitches, the innovative chat app from the creators of HWN. Join meaningful conversations on health and medical topics. Share text, images, and videos seamlessly. Connect directly within HWN's topic pages and articles.


Be the first to know when Stitches starts accepting users


Health Cloud

Stay Connected